An interventional study of FAM-ICU in Delirium, Anxiety and Post Intensive Care Unit Syndrome, sponsored by Herlev Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Herlev Hospital · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Delirium with a site in Denmark — 1 open to participants now, 3 under way, 1 of them phase 3. Delirium · Denmark.
Among the 26 studies in Delirium with a site in Denmark, this one is the 10th largest by enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2025, is one of 8 with no phase, and was the 26th registered.
935 studies on the registry are indexed under Delirium; 188 are open to participants now.
Browse Delirium studies →1 of the 26 studies in Delirium with a site in Denmark is open now. Recruiting first, the newest first:
University of Aarhus · Sites in Denmark
Ages 75+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is below the median of 111 across 551 interventional studies indexed under Delirium.
Median enrollment 175 across the 12 interventional studies, 172 across the 14 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 26 have an industry lead sponsor. The 10 most frequent:
Herlev Hospital is the lead sponsor of 201 studies on the registry; 24 are open to participants now.
Herlev Hospital has 2 studies filed under Delirium — fewer than ten, so there is no comparison to draw.
2 of the studies in Delirium with a site in Denmark that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05895838Phase 3Christian HassagerThe Danish Out-of-Hospital Cardiac Arrest Study | 2027-09 |
| NCT06938789University of AarhusHow Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 26 studies in Delirium with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background: In the intensive care unit (ICU), delirium in patients and long-term mental health challenges in both patients and their family members are highly prevalent. To address these issues, patient- and family-centered care has been recommended to alleviate the burdens associated with critical illness and ICU admission. We have developed the patient- and FAMily-centered care in the adult ICU intervention (FAM-ICU intervention). This multi-component intervention comprises several concrete and manageable components and operationalizing patient- and family-centered care principles in clinical practice. In this protocol, we describe a study aiming to evaluate the feasibility and acceptability of the FAM-ICU intervention in the adult ICU setting, including the feasibility of collecting relevant patient- and family-member outcome data.
Referenc: Bohart et al. 2024. Acta Anaesthesiol Scand
. 2025 Jan;69(1):e14539. doi: 10.1111/aas.14539. Epub 2024 Oct 24. Method: We will conduct a pre-/post two-group study design. We plan to recruit 30 adult ICU patients and their close family members at Herlev University Hospital in Denmark. The pre-group (n = 15) will receive usual care and the post-group (n = 15) will receive the FAM-ICU intervention. The FAM-ICU intervention involves interdisciplinary training of the ICU team and a systematic approach to information sharing and consultations with the patients and their family. Feasibility outcomes will include recruitment and retention rates, intervention fidelity, and the feasibility of participant outcome data collection. Acceptability will be assessed through questionnaires and interviews with clinicians, patients, and family members. Data collection is scheduled to begin in January 2025.
Discussion: This study will assess the feasibility and acceptability when implementing the FAM-ICU intervention and the feasibility of conducting a main trial to investigate its effectiveness on delirium in patients and the mental health of patients and family members. The data from the feasibility study will be used to guide sample size calculations, trial design, and final data collection methods for a subsequent stepped-wedge randomized controlled trial.
Patients are eligible if they are:
Family members are eligible if they are:
The group receives usual care.
The group receives the FAM-ICU intervention
Other: FAM-ICU
This multi-component intervention comprises several concrete and manageable components and operationalizing patient- and family-centered care principles in clinical practice.
Feasibility, recruitment rate
Number of approached participants who consent to participate.
Time frame: during ICU admission.
Feasibility, Retention rate
The number of non-responders to the self-reported questionnaires at 6 months.
Time frame: 1 month post ICU admission
Feasibility, Fidelity
The frequency and resource use of intervention delivery. Free text describing experienced barriers and facilitators for completing/not completing an intervention component.
Time frame: during ICU admission.
Acceptability, Adherence
Willingness to follow the intervention (Including barriers and facilitators).
Time frame: during ICU admission.
Acceptability, Appropriateness
Perception of how suitable the intervention is for the target population,
Time frame: during ICU admission.
Acceptability, Convenience
The intervention intrusiveness (how easy is it to apply)
Time frame: during ICU admission.
Acceptability, effectiveness
Perception of whether the intervention helps manage the problem.
Time frame: during ICU admission.
Free of delirium
Number of delirium free days assessed by Confusion assessment method ICU (CAM-ICU)
Time frame: during ICU admission.
Anxiety, patients
Symptoms of anxiety, using Hospital Anxiety and Depression Scale
Time frame: 1 month post ICU admission
Depression, patients
Symptoms of depression using Hospital Anxiety and Depression Scale.
Time frame: 1 month post ICU admission
PTSD, patients
Symptoms of PTSD using Harvard Trauma Questionnaire part 4 (HTQ-lV).
Time frame: 1 month post ICU admission
Health-related quality of life, patients
Assessed using EQ-5D
Time frame: 1 month post ICU admission
Free of life support
Days without mechanical ventilation, receiving vasopressors and undergoing dialysis.
Time frame: during ICU admission.
Survival
Days alive.
Time frame: 1 month post ICU admission
Employment status, patient
Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.
Time frame: 1 month post ICU admission
Cognitive function
Assessed using Mini Montreal Cognitive Assessment (Mini MoCA).
Time frame: 1 month post ICU admission
Out of hospital
Number of days out of hospital
Time frame: 1 month post ICU admission
Anxiety, family
Symptoms of anxiety using HADS
Time frame: 1 month post ICU admission
Depression, family
Symptoms of depression using HADS
Time frame: 1 post ICU admission
PTSD, family
Symptoms of PTSD using HTQ
Time frame: 1 month post ICU admission
Satisfaction, family
Survey for family-members regarding satisfaction.
Time frame: At ICU discharge.
Employment status, family
Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.
Time frame: 1 month post ICU admission
Anxiety, patients
Symptoms of anxiety, using Hospital Anxiety and Depression Scale
Time frame: 6 months post ICU
Depression, patients
Symptoms of depression using Hospital Anxiety and Depression Scale.
Time frame: 6 months post ICU
PTSD, patients
Symptoms of PTSD using Harvard Trauma Questionnaire part 4 (HTQ-lV).
Time frame: 6 months post ICU
Health-related quality of life, patients
Assessed using EQ-5D
Time frame: 6 months post ICU
Survival
Days alive.
Time frame: 6 months post ICU
Employment status, patient
Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.
Time frame: 6 months post ICU
Cognitive function
Assessed using Mini Montreal Cognitive Assessment (Mini MoCA).
Time frame: 6 months post ICU
Anxiety, family
Symptoms of anxiety using HADS
Time frame: 6 months post ICU
Depression, family
Symptoms of depression using HADS
Time frame: 6 months post ICU
PTSD, family
Symptoms of PTSD using HTQ
Time frame: 6 months post ICU
Employment status
Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.
Time frame: 6 months post ICU
Employment status, family
Employment as full-time, part-time, unemployed, self-employed, (paid/unpaid) on leave, student, or retired.
Time frame: 6 months post ICU
Out of hospital
Number of days out of hospital
Time frame: 6 months post ICU
Plan to share: Undecided
Ran from Nov 2025 to primary completion in May 2026, 6 months.
Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 6 months is below that.
Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: start Aug 2025 → Nov 2025, primary completion Dec 2025 → May 2026 and completion Aug 2026 → Oct 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.